Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

A mitochondrial etiology of Alzheimer and Parkinson disease.

Coskun P, Wyrembak J, Schriner SE, Chen HW, Marciniack C, Laferla F, Wallace DC.

Biochim Biophys Acta. 2012 May;1820(5):553-64. doi: 10.1016/j.bbagen.2011.08.008. Epub 2011 Aug 16. Review.

2.

Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia.

Coskun PE, Wyrembak J, Derbereva O, Melkonian G, Doran E, Lott IT, Head E, Cotman CW, Wallace DC.

J Alzheimers Dis. 2010;20 Suppl 2:S293-310. doi: 10.3233/JAD-2010-100351.

3.

Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease.

Yan MH, Wang X, Zhu X.

Free Radic Biol Med. 2013 Sep;62:90-101. doi: 10.1016/j.freeradbiomed.2012.11.014. Epub 2012 Nov 29.

4.

A mitochondrial etiology of neurodegenerative diseases: evidence from Parkinson's disease.

Khusnutdinova E, Gilyazova I, Ruiz-Pesini E, Derbeneva O, Khusainova R, Khidiyatova I, Magzhanov R, Wallace DC.

Ann N Y Acad Sci. 2008 Dec;1147:1-20. doi: 10.1196/annals.1427.001.

PMID:
19076426
5.

No evidence of association between common European mitochondrial DNA variants in Alzheimer, Parkinson, and migraine in the Spanish population.

Fachal L, Mosquera-Miguel A, Pastor P, Ortega-Cubero S, Lorenzo E, Oterino-Durán A, Toriello M, Quintáns B, Camiña-Tato M, Sesar A, Vega A, Sobrido MJ, Salas A.

Am J Med Genet B Neuropsychiatr Genet. 2015 Jan;168B(1):54-65. doi: 10.1002/ajmg.b.32276. Epub 2014 Oct 28.

PMID:
25349034
6.

Mitochondrial biogenesis: pharmacological approaches.

Valero T.

Curr Pharm Des. 2014;20(35):5507-9.

PMID:
24606795
7.

Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.

Manczak M, Reddy PH.

Hum Mol Genet. 2012 Dec 1;21(23):5131-46. doi: 10.1093/hmg/dds360. Epub 2012 Aug 27.

8.

Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines.

Trimmer PA, Swerdlow RH, Parks JK, Keeney P, Bennett JP Jr, Miller SW, Davis RE, Parker WD Jr.

Exp Neurol. 2000 Mar;162(1):37-50.

PMID:
10716887
9.

Evidence for sub-haplogroup h5 of mitochondrial DNA as a risk factor for late onset Alzheimer's disease.

Santoro A, Balbi V, Balducci E, Pirazzini C, Rosini F, Tavano F, Achilli A, Siviero P, Minicuci N, Bellavista E, Mishto M, Salvioli S, Marchegiani F, Cardelli M, Olivieri F, Nacmias B, Chiamenti AM, Benussi L, Ghidoni R, Rose G, Gabelli C, Binetti G, Sorbi S, Crepaldi G, Passarino G, Torroni A, Franceschi C.

PLoS One. 2010 Aug 6;5(8):e12037. doi: 10.1371/journal.pone.0012037.

10.

Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication.

Coskun PE, Beal MF, Wallace DC.

Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10726-31. Epub 2004 Jul 9.

11.

Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first?

Mancuso M, Orsucci D, Siciliano G, Murri L.

Curr Alzheimer Res. 2008 Oct;5(5):457-68.

PMID:
18855587
12.

Mitochondrial DNA deletions/rearrangements in parkinson disease and related neurodegenerative disorders.

Gu G, Reyes PE, Golden GT, Woltjer RL, Hulette C, Montine TJ, Zhang J.

J Neuropathol Exp Neurol. 2002 Jul;61(7):634-9.

PMID:
12125742
13.

Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases.

Egensperger R, Kösel S, Schnopp NM, Mehraein P, Graeber MB.

Neuropathol Appl Neurobiol. 1997 Aug;23(4):315-21.

PMID:
9292870
14.

Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease.

Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD.

Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14670-5. doi: 10.1073/pnas.0903563106. Epub 2009 Aug 10.

15.

mtDNA mutations and common neurodegenerative disorders.

Howell N, Elson JL, Chinnery PF, Turnbull DM.

Trends Genet. 2005 Nov;21(11):583-6. Epub 2005 Sep 8. Review.

PMID:
16154228
16.

Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.

Perfeito R, Cunha-Oliveira T, Rego AC.

Free Radic Biol Med. 2013 Sep;62:186-201. doi: 10.1016/j.freeradbiomed.2013.05.042. Epub 2013 Jun 3. Review.

PMID:
23743292
17.

The role of mitochondrial disturbances in Alzheimer, Parkinson and Huntington diseases.

Carvalho C, Correia SC, Cardoso S, Plácido AI, Candeias E, Duarte AI, Moreira PI.

Expert Rev Neurother. 2015;15(8):867-84. doi: 10.1586/14737175.2015.1058160. Epub 2015 Jun 19. Review.

PMID:
26092668
18.

Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing.

Coon KD, Valla J, Szelinger S, Schneider LE, Niedzielko TL, Brown KM, Pearson JV, Halperin R, Dunckley T, Papassotiropoulos A, Caselli RJ, Reiman EM, Stephan DA.

Mitochondrion. 2006 Aug;6(4):194-210. Epub 2006 Jul 21.

PMID:
16920408
19.

Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's disease.

Onyango I, Khan S, Miller B, Swerdlow R, Trimmer P, Bennett P Jr.

J Alzheimers Dis. 2006 Jul;9(2):183-93. Review.

PMID:
16873965
20.

Etiology and pathophysiology of frontotemporal dementia, Parkinson disease and Alzheimer disease: lessons from genetic studies.

Wider C, Wszolek ZK.

Neurodegener Dis. 2008;5(3-4):122-5. doi: 10.1159/000113680. Epub 2008 Mar 6. Review.

Supplemental Content

Support Center